Qube Research & Technologies (QRT)
ALPN

Qube Research & Technologies (QRT)’s Alpine Immune Sciences Inc ALPN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-163,323
Closed -$6.47M – 4937
2024
Q1 		$6.47M Sell
163,323
-42,443
-21% -$1.25M 0.01% 1074
2023
Q4 		$3.92M Buy
205,766
+195,696
+1,943% +$2.72M 0.01% 1172
2023
Q3 		$115K Buy
+10,070
New +$124K ﹤0.01% 2612
2021
Q2 		– Sell
-14,562
Closed -$154K – 2913
2021
Q1 		$154K Sell
14,562
-31,994
-69% -$399K ﹤0.01% 1694
2020
Q4 		$587K Buy
46,556
+9,179
+25% +$90.1K 0.01% 1057
2020
Q3 		$329K Buy
+37,377
New +$342K ﹤0.01% 1200

Qube Research & Technologies (QRT)'s ALPN Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 163,323 shares — an estimated $6.47M sold.

Qube Research & Technologies (QRT) first reported a position in ALPN in Q3 2020 and held it in 6 quarters. The position peaked at $6.47M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 163,323 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $6.47M.
  • Qube Research & Technologies (QRT) first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Alpine Immune Sciences Inc position peaked at $6.47M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.